An Oral p38 Inhibitor Investigating Safety, Efficacy, And PK In Subjects With Active Rheumatoid Arthritis

Clinical trial NCT00383188 · COMPLETED

Trial details

NCT number: NCT00383188
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Arthritis, Rheumatoid

Start date: 2006-12-15
Primary completion: 2008-07-01
Enrollment: 305

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.